Z3 Capital Partners »

Crispr Therapeutics shares owned by Z3 Capital Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Z3 Capital Partners from 13F filings

Historical chart of Z3 Capital Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Z3 Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Z3 Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $297k 6.3k 47.57
2025-12-31 $275k 5.3k 52.44

More positions owned by Z3 Capital Partners

ClearBridge Energy MLP Fund (EMO)
Palantir Technologies Incorporated Class A Cl A (PLTR)
Bank of America Corporation (BAC)
NVIDIA Corporation (NVDA)
Hancock John Finl Opptys Sh Ben Int Sh Ben Int New (BTO)
Blackrock Science & Technology SHS (BST)
Amazon (AMZN)
Neuberger Next Generation Common Stock (NBXG)
Alphabet Incorporated Cap Stk Class A Cap Stk Cl A (GOOGL)
Pacer Fds Tr Us Large Cap Cash Cows Us Lrg Cp Cash (COWG)
Tesla Motors (TSLA)
Ft Vest Smid Rising Divid Achievers Target Ft Vest Smid (SDVD)
Microsoft Corporation (MSFT)
Blackrock Science & Technology Shs Ben Int Shs Ben Int (BSTZ)
Micron Technology (MU)

View all positions for Z3 Capital Partners

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Susquehanna International
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Two Sigma Investments

View all funds holding Crispr Therapeutics